184
Participants
Start Date
October 25, 2019
Primary Completion Date
February 16, 2026
Study Completion Date
March 31, 2027
PED-HZ/su
GSK's candidate vaccine- PED-HZ/su. is administered intramuscularly in the deltoid of the non-dominant arm, on a two-dose schedule in the two investigational groups.
RECRUITING
GSK Investigational Site, Brussels
RECRUITING
GSK Investigational Site, Leuven
RECRUITING
GSK Investigational Site, Liège
RECRUITING
GSK Investigational Site, Ghent
RECRUITING
GSK Investigational Site, Torino
RECRUITING
GSK Investigational Site, Marseille
COMPLETED
GSK Investigational Site, Genova
RECRUITING
GSK Investigational Site, Milan
RECRUITING
GSK Investigational Site, Madrid
RECRUITING
GSK Investigational Site, Madrid
RECRUITING
GSK Investigational Site, Toulouse
RECRUITING
GSK Investigational Site, Bordeaux
RECRUITING
GSK Investigational Site, Montpellier
RECRUITING
GSK Investigational Site, Padua
RECRUITING
GSK Investigational Site, Seville
WITHDRAWN
GSK Investigational Site, Nantes
RECRUITING
GSK Investigational Site, BaracaldoVizcaya
RECRUITING
GSK Investigational Site, Lille
RECRUITING
GSK Investigational Site, Paris
RECRUITING
GSK Investigational Site, Paris
RECRUITING
GSK Investigational Site, Roma
RECRUITING
GSK Investigational Site, Gdansk
COMPLETED
GSK Investigational Site, Espluges de Llobregat
RECRUITING
GSK Investigational Site, HebrOn
RECRUITING
GSK Investigational Site, Birmingham
COMPLETED
GSK Investigational Site, Cardiff
RECRUITING
GSK Investigational Site, Glasgow Strathclyde
RECRUITING
GSK Investigational Site, London
RECRUITING
GSK Investigational Site, Manchester
RECRUITING
GSK Investigational Site, Nottingham
RECRUITING
GSK Investigational Site, Southampton
Lead Sponsor
GlaxoSmithKline
INDUSTRY